Book contents
- Management of Chronic Pelvic Pain
- Management of Chronic Pelvic Pain
- Copyright page
- Contents
- Contributors
- Foreword
- Chapter 1 Introduction to Chronic Pelvic Pain
- Chapter 2 Neurobiological Basis of Pelvic Pain
- Chapter 3 History and Evaluation of Patients with Chronic Pelvic Pain
- Chapter 4 Psychological Assessment of a Female Patient with Chronic Pelvic Pain
- Chapter 5 Musculoskeletal Assessment for Patients with Pelvic Pain
- Chapter 6 Pharmacological Management of Patients with Pelvic Pain
- Chapter 7 Evidence for Surgery for Pelvic Pain
- Chapter 8 Pelvic Pain Arising from Endometriosis
- Chapter 9 Bladder Pain Syndrome
- Chapter 10 Pelvic Pain Arising from Pelvic Congestion Syndrome
- Chapter 11 Irritable Bowel Syndrome
- Chapter 12 Vulvodynia
- Chapter 13 Pelvic Pain Arising from Adhesive Disease
- Chapter 14 Pelvic Pain Arising from Ovarian Remnant Syndrome
- Chapter 15 Pudendal Neuralgia
- Chapter 16 Other Peripheral Pelvic Neuralgias
- Chapter 17 Chronic Pain After Gynecological Surgery
- Chapter 18 Pain Arising from Pelvic Mesh Implants
- Chapter 19 Treatment of Sexual Dysfunction Arising from Chronic Pelvic Pain
- Chapter 20 Physical Therapy Interventions for Musculoskeletal Impairments in Pelvic Pain
- Chapter 21 If Everything Else Fails
- Index
- References
Chapter 11 - Irritable Bowel Syndrome
Published online by Cambridge University Press: 08 March 2021
Edited by
Book contents
- Management of Chronic Pelvic Pain
- Management of Chronic Pelvic Pain
- Copyright page
- Contents
- Contributors
- Foreword
- Chapter 1 Introduction to Chronic Pelvic Pain
- Chapter 2 Neurobiological Basis of Pelvic Pain
- Chapter 3 History and Evaluation of Patients with Chronic Pelvic Pain
- Chapter 4 Psychological Assessment of a Female Patient with Chronic Pelvic Pain
- Chapter 5 Musculoskeletal Assessment for Patients with Pelvic Pain
- Chapter 6 Pharmacological Management of Patients with Pelvic Pain
- Chapter 7 Evidence for Surgery for Pelvic Pain
- Chapter 8 Pelvic Pain Arising from Endometriosis
- Chapter 9 Bladder Pain Syndrome
- Chapter 10 Pelvic Pain Arising from Pelvic Congestion Syndrome
- Chapter 11 Irritable Bowel Syndrome
- Chapter 12 Vulvodynia
- Chapter 13 Pelvic Pain Arising from Adhesive Disease
- Chapter 14 Pelvic Pain Arising from Ovarian Remnant Syndrome
- Chapter 15 Pudendal Neuralgia
- Chapter 16 Other Peripheral Pelvic Neuralgias
- Chapter 17 Chronic Pain After Gynecological Surgery
- Chapter 18 Pain Arising from Pelvic Mesh Implants
- Chapter 19 Treatment of Sexual Dysfunction Arising from Chronic Pelvic Pain
- Chapter 20 Physical Therapy Interventions for Musculoskeletal Impairments in Pelvic Pain
- Chapter 21 If Everything Else Fails
- Index
- References
Summary
Irritable bowel syndrome (IBS) is another condition of the “evil quadruplets.” It often coexists with endometriosis and adds to the pain of this condition. The mainstay is pain that is worsened by food and improved by defecation. It is also important to remember that IBS is diagnosed based on symptoms, and endoscopy is often performed in those patients is done to rule out any other bowel disease. This condition is best managed by a gastroenterologist but it is important to note that quite a large number of patients with this condition have spasm of pelvic floor muscles and treatment of that spasm may improve some of the IBS symptoms.
- Type
- Chapter
- Information
- Management of Chronic Pelvic PainA Practical Manual, pp. 120 - 128Publisher: Cambridge University PressPrint publication year: 2021
References
Chey, WD, Kurlander, J, Eswaran, S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313(9):949–58.Google ScholarPubMed
Lovell, RM, Ford, AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10:712.CrossRefGoogle ScholarPubMed
Sayuk, GS, Wolf, R, Chang, L. Comparison of symptoms, healthcare utilization, and treatment in diagnosed and undiagnosed individuals with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol. 2017;112:892–9.CrossRefGoogle ScholarPubMed
Olafsdottir, LB, Gudjonsson, H, Jonsdottir, HH, Jonsson, JS, et al. Irritable bowel syndrome: physicians’ awareness and patients’ experience. World J Gastroenterol. 2012;18(28):3715–20.CrossRefGoogle ScholarPubMed
Suttor, VP, Prott, GM, Hansen, RD, Kellow, JE, Malcolm, A. Evidence for pelvic floor dyssynergia in patients with irritable bowel syndrome. Dis Colon Rectum. 2010;53(2):156–60.Google Scholar
Saha, L. Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. World J Gastroenterol. 2014;20(22):6759–73.CrossRefGoogle ScholarPubMed
Alaradi, O, Barkin, J. Irritable bowel syndrome: update on pathogenesis and management. Med Princ Pract. 2002;11(1):2–17.Google Scholar
Camilleri, M. Peripheral mechanisms in irritable bowel syndrome. N Engl J Med. 2012;367(17):1626–35. DOI: 10.1056/NEJMra1207068.Google Scholar
Lee, YJ, Park, KS. Irritable bowel syndrome: emerging paradigm in pathophysiology. World J Gastroenterol. 2014;10(20):2456–69. DOI: 10.3748/wjg.v20.i10.2456.Google Scholar
Altobelli, E, Del Negro, V, Angeletti, PM, et al. Low-FODMAP diet improves irritable bowel syndrome symptoms: a meta-analysis. Nutrients. 2017;9:940; DOI: 10.3390/nu9090940.CrossRefGoogle ScholarPubMed
Lacy, BE. Rome criteria and a diagnostic approach to irritable bowel syndrome. J Clin Med. 2017;6(11):99.CrossRefGoogle Scholar
Yang, J, Deng, Y, Chu, H, et al. Prevalence and presentation of lactose intolerance and effects on dairy product intake in healthy subjects and patients with irritable bowel syndrome. Clin Gastroenterol and Hepatol. 2013;11:262–8.Google Scholar
Zhang, Y, Li, L, Guo, C, et al. Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis. BMC Gastroenterol. 2016;16(1):62.CrossRefGoogle ScholarPubMed
Vazquez-Roque, MI, Camelleri, M, Smyrk, T, et al. A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology. 2013;144(5):903–11. e.3.Google Scholar
Camilleri, M, Ford, AC. Pharmacotherapy for irritable bowel syndrome. J Clin Med. 2017;6:101. DOI: 10.3390/jcm6110101.Google Scholar
Rao, S, Lembo, AJ, Shiff, SJ, et al. A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation. Am J Gastroenterol. 2012;107:1714–24. DOI: 10.1038/ajg.2012.255.CrossRefGoogle ScholarPubMed
Chey, WD, Lembo, AJ, Lavins, BJ, et al. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety. Am J Gastroenterol. 2012; 107:1702–12; DOI: 10.1038/ajg.2012.254.Google Scholar
Weinberg, DS, Smalley, W, Heidelbaugh, JJ, et al. American Gastroenterological Association Institute guideline on the pharmacological management of irritable bowel syndrome. Gastroenterology. 2014;147:1146–8.Google Scholar
Lembo, AJ, Lacy, BE, Zuckerman, M, et al. Eluxadoline for irritable bowel syndrome with diarrhea. N Engl J Med. 2016;374:242–53. DOI: 10.1056/NEJMoa1505180.CrossRefGoogle ScholarPubMed
Soares, RL. Irritable bowel syndrome: a clinical review. World J Gastroenterol.Google Scholar